These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2783415

  • 1. Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor.
    Ozawa S, Ueda M, Ando N, Abe O, Minoshima S, Shimizu N.
    Int J Cancer; 1989 Jan 15; 43(1):152-7. PubMed ID: 2783415
    [Abstract] [Full Text] [Related]

  • 2. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [Abstract] [Full Text] [Related]

  • 3. Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor.
    Osaku M, Ueda M, Ando N, Shinozawa Y, Hirota N, Shimizu N, Abe O.
    Anticancer Res; 1991 Dec 15; 11(6):1951-6. PubMed ID: 1723259
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin.
    Jinno H, Ueda M, Ozawa S, Kikuchi K, Ikeda T, Enomoto K, Kitajima M.
    Cancer Chemother Pharmacol; 1996 Dec 15; 38(4):303-8. PubMed ID: 8674151
    [Abstract] [Full Text] [Related]

  • 5. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM, Hackel BJ, Rosenblum MG, Wittrup KD.
    J Biol Chem; 2011 Feb 11; 286(6):4165-72. PubMed ID: 21138845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov 11; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 11. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG, Zuckerman JE, Marks JW, Rotbein J, Allen WR.
    Mol Biother; 1992 Sep 11; 4(3):122-9. PubMed ID: 1445665
    [Abstract] [Full Text] [Related]

  • 12. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
    Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG.
    Cancer Immunol Immunother; 1991 Sep 11; 34(3):198-204. PubMed ID: 1756537
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor.
    O'Boyle KP, Colletti D, Mazurek C, Wang Y, Ray SK, Diamond B, Rosenblum MG, Epstein AL, Shochat D, Dutcher JP.
    J Immunother Emphasis Tumor Immunol; 1995 Nov 11; 18(4):221-30. PubMed ID: 8680650
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor-dependent cytotoxic effect of anti-EGFR antibody-ribonuclease conjugate on human cancer cells.
    Suwa T, Ueda M, Jinno H, Ozawa S, Kitagawa Y, Ando N, Kitajima M.
    Anticancer Res; 1999 Nov 11; 19(5B):4161-5. PubMed ID: 10628369
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor.
    Behzadian MA, Shimizu N.
    Cell Struct Funct; 1985 Sep 11; 10(3):219-32. PubMed ID: 2994889
    [Abstract] [Full Text] [Related]

  • 16. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells.
    Rosenblum MG, Cheung L, Kim SK, Mujoo K, Donato NJ, Murray JL.
    Cancer Immunol Immunother; 1996 Feb 11; 42(2):115-21. PubMed ID: 8620520
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J.
    Cancer Res; 1989 Jul 01; 49(13):3482-8. PubMed ID: 2786451
    [Abstract] [Full Text] [Related]

  • 18. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
    Sivam G, Pearson JW, Bohn W, Oldham RK, Sadoff JC, Morgan AC.
    Cancer Res; 1987 Jun 15; 47(12):3169-73. PubMed ID: 3495329
    [Abstract] [Full Text] [Related]

  • 19. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
    Pagliaro LC, Liu B, Munker R, Andreeff M, Freireich EJ, Scheinberg DA, Rosenblum MG.
    Clin Cancer Res; 1998 Aug 15; 4(8):1971-6. PubMed ID: 9717827
    [Abstract] [Full Text] [Related]

  • 20. Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro.
    Barnett BB, Burns NJ, Park KJ, Dawson MI, Kende M, Sidwell RW.
    Antiviral Res; 1991 Feb 15; 15(2):125-38. PubMed ID: 1650165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.